{"id":522069,"date":"2021-08-03T08:04:32","date_gmt":"2021-08-03T12:04:32","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/"},"modified":"2021-08-03T08:04:32","modified_gmt":"2021-08-03T12:04:32","slug":"rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/","title":{"rendered":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEWARK, Calif., Aug.  03, 2021  (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter that ended June 30, 2021 and highlights of recent progress, on Tuesday, August 10, 2021. On that day, management will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss the Company\u2019s business and financial results.<\/p>\n<p>\n        <strong>Conference Call and Webcast Details:<\/strong><br \/>\n        <br \/>Date: August 10, 2021<br \/>Time: 1:30 p.m. PT (4:30 p.m. ET)<br \/>Dial In Numbers: 1 (800) 708-4539 (U.S. Toll Free) \/ 1 (847) 619-6396 (U.S. Toll)<br \/>Passcode: 50202648<br \/>Webcast Link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QPt9_q6l87LWCdfvGZlnfUchJysYNhzGwRK431s3DIfWp3Wnpi8wBBtPpIXqzdJ0M9F7cLP9F259ZLRA5Qz8lFLNKZd13Yd44h6gD6kSuN-_ms9S3hTSfVTeibwke3KaFJdeDJ19v7aqubDREQ9VzsjnWLXcAvqDI-8eiVy6v9F5sHZL-MBUpRdOZmb8kGNNmepvj7ahIzooBXBQ9Q4u9rSl9znS4LdqDfDG0_hzRgdG3kW1DHgTqS2ndnJ442m-rmT7xnjYfDA-bKVx3Dbn-QeBgwJC977jn82BUKczLyoQwJEuU2z7zark5_MuiaJydi4pNH1VdWbw2285xwbwd8RXuR3WFI8jWMgk4nNcfGrF1FGwCdUwnOsIMnHGTxvOy9HZYyNC311VX7hXi75DeFNGQa_OAmvIxVFV4coLOk1JcN7vaRPQfKbuG-ApfgqO52lWzG7JXeIGqjLJ1Ut9-CamjfBYf0NvDwqrF2hrw6uwVnc7qbNMl4iemyAOBRZEKEWrCSGreAN2wXkS6QXS8_ZZoDjRI1p3-t9t0ERdyHLuNiVsGswIBpYlQTXJn05ecCr78GKZUT9p8bCSXUl1BUHyJ3_6J7-TT3r9RhINTBB0NyNaJ76iro-AEokOYg6_WH8O_kNkUkj7lhOLpgoH-aCI2mnV6bGYZfNsZZsGhw0CRq8EqDnfU-Ii2tfhzUJpxUsSaAlaDy8f-HvCdn3T1H0rT3h5eGntgWjdjkqOusNOdOvo2mgr-hEgL8H8CU1v0o-Y3zCzj4o1it4HUY1YlKLrYUM4dfei4T1tYbW0ahCTkaIRrkpXX7XIXVes7AJ5qMTYRinkGoDXwJUN_z-aLJHPUARlUXorAvi-VQMmg7Q=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/4ar5rh24<\/a><\/p>\n<p>The call will be recorded and available for replay on the Company\u2019s website for approximately 30 days after the call.<\/p>\n<p>\n        <strong>About Rain Therapeutics Inc.<\/strong><br \/>\n        <br \/>Rain Therapeutics Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers for which it is able to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors\u2019 underlying genetics rather than histology. Rain\u2019s lead product candidate, milademetan (RAIN-32), is a small molecule, oral inhibitor of MDM2, which is oncogenic in numerous cancers. In addition to milademetan, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MhgXaMU3kuNHYSZ0YtkmXje8QRn6qJsRpg35cv6GR8ey76CKN_51GToJJ1al9_ltY6B2xtzJP4GCqTjNsrDXLw==\" rel=\"nofollow noopener\" target=\"_blank\">www.rainthera.com<\/a>.<\/p>\n<p>\n        <strong>Media Contact for Rain:<\/strong><br \/>\n        <br \/>Grace Fotiades<br \/>LifeSci Communications<br \/>+1.646.876.5026<br \/>gfotiades@lifescicomms.com<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/9b741166-6709-45a3-a73f-0b4694ed1466\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEWARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter that ended June 30, 2021 and highlights of recent progress, on Tuesday, August 10, 2021. On that day, management will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2021Time: 1:30 p.m. PT (4:30 p.m. ET)Dial In Numbers: 1 (800) 708-4539 (U.S. Toll Free) \/ 1 (847) 619-6396 (U.S. Toll)Passcode: 50202648Webcast Link: https:\/\/edge.media-server.com\/mmc\/p\/4ar5rh24 The call will be recorded and available for replay on the Company\u2019s website for approximately 30 &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-522069","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter that ended June 30, 2021 and highlights of recent progress, on Tuesday, August 10, 2021. On that day, management will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2021Time: 1:30 p.m. PT (4:30 p.m. ET)Dial In Numbers: 1 (800) 708-4539 (U.S. Toll Free) \/ 1 (847) 619-6396 (U.S. Toll)Passcode: 50202648Webcast Link: https:\/\/edge.media-server.com\/mmc\/p\/4ar5rh24 The call will be recorded and available for replay on the Company\u2019s website for approximately 30 &hellip; Continue reading &quot;Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-03T12:04:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021\",\"datePublished\":\"2021-08-03T12:04:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/\",\"name\":\"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\",\"datePublished\":\"2021-08-03T12:04:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/","og_locale":"en_US","og_type":"article","og_title":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk","og_description":"NEWARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) &#8212; Rain Therapeutics Inc., (NasdaqGS: RAIN) a late-stage company developing precision oncology therapeutics, today announced it will report financial results for the second quarter that ended June 30, 2021 and highlights of recent progress, on Tuesday, August 10, 2021. On that day, management will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss the Company\u2019s business and financial results. Conference Call and Webcast Details: Date: August 10, 2021Time: 1:30 p.m. PT (4:30 p.m. ET)Dial In Numbers: 1 (800) 708-4539 (U.S. Toll Free) \/ 1 (847) 619-6396 (U.S. Toll)Passcode: 50202648Webcast Link: https:\/\/edge.media-server.com\/mmc\/p\/4ar5rh24 The call will be recorded and available for replay on the Company\u2019s website for approximately 30 &hellip; Continue reading \"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-03T12:04:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021","datePublished":"2021-08-03T12:04:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/","name":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=","datePublished":"2021-08-03T12:04:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMDk2NCM0MzE3NzAyIzIyMDYxOTk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rain-therapeutics-to-report-second-quarter-2021-financial-results-and-highlights-of-recent-progress-on-august-10-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rain Therapeutics to Report Second Quarter 2021 Financial Results and Highlights of Recent Progress on August 10, 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522069","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=522069"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/522069\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=522069"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=522069"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=522069"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}